404
Rapid Diagnostic Kits Market Analysis | 2023-2028
Rapid Diagnostic Kits Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
Rapid Diagnostic Kits Market is segmented by Product Type (Over The Counter (OTC) Kits, Professional Kits), by Technology Type (Lateral Flow, Agglutination, Solid Phase, Others), by Application Type (Blood Glucose Testing, Infectious Disease Testing, Cardiometabolic Testing, Pregnancy, and Fertility Testing, Fecal Occult Blood Testing, Coagulation Testing, Toxicology Testing, Lipid Profile Testing, and Others), by End Use Type (Hospitals & Clinics, Home Care, Diagnostic Laboratories), and by Region - COVID-19 Impact Analysis and Forecast to 2028.
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. You may request a complimentary preview of the report through a video conference with our team.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
The healthcare industry recently focused on expediting disease diagnosis through testing. Consequently, rapid diagnostic test kits have been developed to offer instant access to diagnose patients with various types of diseases and decide the kind of required treatment. These rapid diagnostic kits offer quick results and are cost-effective and easily available.
The rapid diagnostic kits market was estimated at USD 14.7 billion in 2022,
The rapid diagnostic kits market is likely to reach USD 18.3 billion in 2028.
The rapid diagnostic kits market is likely to grow at a CAGR of 3.66% during 2023-2028.
Acon Laboratories, Inc. (The U.S), Alfa Scientific Designs Inc. (The U.S), Abbott Laboratories (The U.S), Artron Laboratories Inc. (Canada), Becton, Dickinson And Company (The U.S), BTNX Inc (Canada), bioMérieux SA (France), Bio-Rad Laboratories, Inc. (The U.S), Cardinal Health (The U.S) and Danaher Corporation (The U.S) are among the top players in the market.
North America witnessed the highest share in the market in 2022.
The over-the-counter kits segment garnered the highest market share of more than 50% in 2022 and is likely to register a substantial CAGR during the review period.
Rapid Diagnostic Kits companies, Rapid Diagnostic Kits vendors, R&D companies, Hospitals, Drug manufacturing companies are the target audience in the market.